Bildkälla: Stockfoto

Fluoguide Q4: Case intact - SEB

Q4 EBIT was DKK -9.6m vs. SEB at DKK -11.9m. Cash amounted to DKK 47m as of the year-end, however, this is complemented by a SEK 25m in a directed issue carried out in March 2022. With the cash position FluoGuide comments that it can finance the two phase II results (brain and lung) with FG001 and provide flexibility in timing of next funding. Nothing in the report that changes our view on the case.

Q4 EBIT was DKK -9.6m vs. SEB at DKK -11.9m. Cash amounted to DKK 47m as of the year-end, however, this is complemented by a SEK 25m in a directed issue carried out in March 2022. With the cash position FluoGuide comments that it can finance the two phase II results (brain and lung) with FG001 and provide flexibility in timing of next funding. Nothing in the report that changes our view on the case.
Börsvärldens nyhetsbrev
ANNONSER